Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7
Original Research
Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
23,045 | Dovepress* | 18,690+ | 1,965 | 20,655 | |
PubMed Central* | 4,355 | 676 | 5,031 | ||
Totals | 23,045 | 2,641 | 25,686 | ||
*Since 12 May 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 2 | 4 |
View citations on PubMed Central and Google Scholar